DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / A•••••
A•••••
Series BUS
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- unknown
- Rounds on record
- 1
- Disclosed raised
- $25.0Msum of rounds with a disclosed amount only
- Named investors
- 3
Financing history
1 rounds
- Dec 12, 2025Series B · $25.0M (disclosed)Q•• I••••••••• G•••• (lead)A•••• P••••••••• F••• (participant)S••••• S•••• V•••••• P••••••• (participant)Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “A••••• Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline”
Investors on record
3 edges
- A•••• P••••••••• F••• round, participant Fact prnewswire.com
- Q•• I••••••••• G•••• round, lead Fact prnewswire.com
- S••••• S•••• V•••••• P••••••• round, participant Fact prnewswire.com
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
- Dec 12, 2025A••••• announced Series B of $25,000,000, led by Q•• I••••••••• G••••Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company
- Round announced: Series B $25,000,000 Dec 12, 2025 Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)